LifeStance Health Group, Inc.
LFST
$4.08
$0.1754.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 109.97% | -19.39% | 74.41% | -10.33% | 53.08% |
| Total Depreciation and Amortization | -6.24% | -2.94% | -18.74% | -17.57% | 1.56% |
| Total Amortization of Deferred Charges | -37.56% | -4.29% | 0.00% | -0.94% | -16.70% |
| Total Other Non-Cash Items | -5.82% | 20.79% | -25.96% | 22.78% | 151.68% |
| Change in Net Operating Assets | -300.93% | 287.08% | -191.33% | 126.35% | -286.68% |
| Cash from Operations | -104.96% | 174.25% | -48.43% | 301.76% | -230.03% |
| Capital Expenditure | -13.76% | -24.75% | 1.15% | -0.12% | 55.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -13.76% | -24.75% | 1.15% | -0.12% | 55.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 99.37% | -39,202.33% | 0.14% | -0.14% | -12.63% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -253.01% | -84.86% | 58.82% | -34.28% |
| Cash from Financing | -145.75% | -100.44% | -41.41% | 41.09% | -107.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -138.95% | 232.07% | -58.30% | 227.73% | -181.10% |